GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Sunho Pharmaceutical Co Ltd (BJSE:430017) » Definitions » Capital Expenditure

Beijing Sunho Pharmaceutical Co (BJSE:430017) Capital Expenditure : ¥-56.29 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Beijing Sunho Pharmaceutical Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Beijing Sunho Pharmaceutical Co's cash flow for capital expenditures for the three months ended in Mar. 2024 was ¥-33.7 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-56.29 Mil.

Beijing Sunho Pharmaceutical Co Capital Expenditure Historical Data

The historical data trend for Beijing Sunho Pharmaceutical Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Sunho Pharmaceutical Co Capital Expenditure Chart

Beijing Sunho Pharmaceutical Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.26 -50.89 -87.19 -73.71 -17.09

Beijing Sunho Pharmaceutical Co Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.35 -5.38 -8.20 -9.06 -33.66

Beijing Sunho Pharmaceutical Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-56.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Sunho Pharmaceutical Co (BJSE:430017) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Sunho Pharmaceutical Co Ltd (BJSE:430017) » Definitions » Capital Expenditure
Comparable Companies
BJSE:832566 SHSE:600530 BJSE:836433 BJSE:833266 BJSE:832735 BJSE:833230 BJSE:873167 BJSE:430478 SHSE:603139 SZSE:002433 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 18, Zhonghe Street, Beijing Economic and Technological Development Zone, Beijing, CHN, 100176
Website
http://www.sunho.com.cn
Beijing Sunho Pharmaceutical Co Ltd engages in the research and development, production, and sales of pharmaceutical preparations while providing CMC/CMO integrated services for pharmaceutical preparation manufacturers and innovative drug R&D enterprises. The company produces small-volume injections, freeze-dried powder injections, hard capsules, tablets, and other products.

Beijing Sunho Pharmaceutical Co (BJSE:430017) Headlines

No Headlines